Mae'r cynnwys hwn ar gael yn Saesneg yn unig.
Trosolwg
Ymchil
Traethawd ymchwil
ADVANCED PERSONALISED 3D DOSIMETRY FOR A CLINICAL TRIAL IN PETIDE RADIONUCLIDE THERAPY.
Cyhoeddiadau
2020
- Spezi, E. et al. 2020. Metabolic tumour volume segmentation for oesophageal cancer on hybrid PET/CT using convolutional network architecture. Presented at: 33rd Annual European Association of Nuclear Medicine Congress (EANM 2020), Virtual, 22-30 October 2020European Journal of Nuclear Medicine and Molecular Imaging, Vol. 47. Vol. S1. Springer Verlag (Germany) pp. 5481-5482., (10.1007/s00259-020-04988-4)
- Berenato, S. 2020. Personalised advanced 3D dosimetry in peptide receptor radionuclide therapy. PhD Thesis, Cardiff University.
- Finocchiaro, D. et al. 2020. Comparison of different calculation techniques for absorbed dose assessment in patient specific peptide receptor radionuclide therapy. PLoS ONE 15(8), article number: e0236466. (10.1371/journal.pone.0236466)
2019
- Finocchiaro, D. et al. 2019. Partial volume effect of SPECT images in PRRT with 177Lu labelled somatostatin analogues: A practical solution. Physica Medica 57, pp. 153-159. (10.1016/j.ejmp.2018.12.029)
2018
- Grassi, E. et al. 2018. Effect of image registration on 3D absorbed dose calculations in 177 Lu-DOTATOC Peptide Receptor Radionuclide Therapy. Physica Medica: European Journal of Medical Physics 45, pp. 177-185. (10.1016/j.ejmp.2017.11.021)
2016
- Berenato, S., Amato, E., Fischer, A. and Baldari, S. 2016. Influence of voxel S factors on three-dimensional internal dosimetry calculations. Physica Medica 32(10), pp. 1259-1262. (10.1016/j.ejmp.2016.09.012)